Two doses of vaccine reduced the risk of COVID-19 sequelae by 41 percent

A study from the United Kingdom showed that people who completed two doses of the COVID-19 vaccine were about 41 percent less likely to have long-term sequelae after recovering from COVID-19.

That’s according to a paper published February 24 on medRxiv by the chief statisticians in the Department of Health Analysis and Life Events at the NATIONAL Statistics Office in Newport, UK, Risk of Long Covid in People infected with SARS-COV-2 after two doses of A COVID-19 vaccine: Community-based, Matched Cohort Study “.

The study included participants aged 18-69 who tested positive for COVID-19 between April 26, 2020, and November 30, 2021, including 3,090 participants who had completed two doses of the COVID-19 vaccine and 452 who had not been vaccinated. Results showed that 294 participants who completed two doses of the COVID-19 vaccine reported long-term novel coronavirus symptoms.

2 thoughts on “Two doses of vaccine reduced the risk of COVID-19 sequelae by 41 percent

  1. David Vogel says:

    I think this is the best explanation of how the mask works, and the info about how to properly clean them for decontamination is the best bit of the video.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.